Oragenics Return On Tangible Assets from 2010 to 2024
OGEN Stock | USD 1.07 0.02 1.90% |
Return On Tangible Assets | First Reported 2010-12-31 | Previous Quarter (4.16) | Current Value (3.95) | Quarterly Volatility 1.66533062 |
Check Oragenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oragenics main balance sheet or income statement drivers, such as Depreciation And Amortization of 26 K, Interest Expense of 58 K or Selling General Administrative of 4.2 M, as well as many exotic indicators such as Price To Sales Ratio of 353, Dividend Yield of 0.0 or PTB Ratio of 2.87. Oragenics financial statements analysis is a perfect complement when working with Oragenics Valuation or Volatility modules.
Oragenics | Return On Tangible Assets |
Latest Oragenics' Return On Tangible Assets Growth Pattern
Below is the plot of the Return On Tangible Assets of Oragenics over the last few years. It is a profitability metric that measures a company's ability to generate earnings from its tangible assets. Oragenics' Return On Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oragenics' overall financial position and show how it may be relating to other accounts over time.
Return On Tangible Assets | 10 Years Trend |
|
Return On Tangible Assets |
Timeline |
Oragenics Return On Tangible Assets Regression Statistics
Arithmetic Mean | (1.74) | |
Coefficient Of Variation | (95.68) | |
Mean Deviation | 1.23 | |
Median | (0.96) | |
Standard Deviation | 1.67 | |
Sample Variance | 2.77 | |
Range | 5.6113 | |
R-Value | (0.09) | |
Mean Square Error | 2.96 | |
R-Squared | 0.01 | |
Significance | 0.76 | |
Slope | (0.03) | |
Total Sum of Squares | 38.83 |
Oragenics Return On Tangible Assets History
About Oragenics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Oragenics income statement, its balance sheet, and the statement of cash flows. Oragenics investors use historical funamental indicators, such as Oragenics's Return On Tangible Assets, to determine how well the company is positioned to perform in the future. Although Oragenics investors may use each financial statement separately, they are all related. The changes in Oragenics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Oragenics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Oragenics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Oragenics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (4.16) | (3.95) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Oragenics Correlation against competitors. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.Note that the Oragenics information on this page should be used as a complementary analysis to other Oragenics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Oragenics Stock analysis
When running Oragenics' price analysis, check to measure Oragenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oragenics is operating at the current time. Most of Oragenics' value examination focuses on studying past and present price action to predict the probability of Oragenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oragenics' price. Additionally, you may evaluate how the addition of Oragenics to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Oragenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.18) | Revenue Per Share 0.017 | Quarterly Revenue Growth (0.91) | Return On Assets (1.32) | Return On Equity (2.55) |
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.